Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Report Date: May 11, 2023
Reporting Period: Quarter ended March 31, 2023
Context: The Company filed this report to announce its financial results for the period ended March 31, 2023, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text serves as a cover document referencing a press release (Exhibit 99.1) for detailed financial data. The text itself does not provide clear values for the following metrics:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Guidance and Outlook: The filing text does not contain management commentary, forward-looking guidance, or specific outlook statements.
Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K filing.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 11, 2023) for actual revenue, net income, and cash flow figures for the quarter ended March 31, 2023.
- Verify the Company's status as an Emerging Growth Company (indicated as checked in the filing) and its implications for financial reporting standards.
- Confirm the trading symbol INBS on The Nasdaq Stock Market LLC.
- Check for any subsequent filings that may incorporate the press release by reference, as this specific 8-K explicitly states the information is not incorporated by reference.